SUMOylation is recently found to function as a targeting signal for the degradation of substrates through the ubiquitin-proteasome system. RNF4 is the most studied human SUMO-targeted ubiquitin E3 ligase. However, the...SUMOylation is recently found to function as a targeting signal for the degradation of substrates through the ubiquitin-proteasome system. RNF4 is the most studied human SUMO-targeted ubiquitin E3 ligase. However, the relationship between SUMO proteases, SENPs, and RNF4 remains obscure. There are limited examples of the SENP regulation of SUMO2/3-targeted proteolysis mediated by RNF4. The present study investigated the role of SENP3 in the global protein turnover related to SUMO2/3-targeted ubiquitination and focused in particular on the SENP3 regulation of the stability of Spl. Our data demonstrated that SENP3 impaired the global ubiquitination profile and promoted the accumulation of many proteins. Spl, a cancer-associated transcription factor, was among these proteins. SENP3 increased the level of Spl protein via antagonizing the SUMO2/3-targeted ubiquitination and the consequent proteasome-dependent degradation that was mediated by RNF4. De-conjugation of SUMO2/3 by SENP3 attenuated the interaction of Spl with RNF4. In gastric cancer cell lines and specimens derived from patients and nude mice, the level of Spl was generally increased in parallel to the level of SENP3. These results provided a new explanation for the enrichment of the Spl protein in various cancers, and revealed a regulation of SUMO2/3 conjugated proteins whose levels may be tightly con- trolled by SENP3 and RNF4.展开更多
文摘SUMOylation is recently found to function as a targeting signal for the degradation of substrates through the ubiquitin-proteasome system. RNF4 is the most studied human SUMO-targeted ubiquitin E3 ligase. However, the relationship between SUMO proteases, SENPs, and RNF4 remains obscure. There are limited examples of the SENP regulation of SUMO2/3-targeted proteolysis mediated by RNF4. The present study investigated the role of SENP3 in the global protein turnover related to SUMO2/3-targeted ubiquitination and focused in particular on the SENP3 regulation of the stability of Spl. Our data demonstrated that SENP3 impaired the global ubiquitination profile and promoted the accumulation of many proteins. Spl, a cancer-associated transcription factor, was among these proteins. SENP3 increased the level of Spl protein via antagonizing the SUMO2/3-targeted ubiquitination and the consequent proteasome-dependent degradation that was mediated by RNF4. De-conjugation of SUMO2/3 by SENP3 attenuated the interaction of Spl with RNF4. In gastric cancer cell lines and specimens derived from patients and nude mice, the level of Spl was generally increased in parallel to the level of SENP3. These results provided a new explanation for the enrichment of the Spl protein in various cancers, and revealed a regulation of SUMO2/3 conjugated proteins whose levels may be tightly con- trolled by SENP3 and RNF4.
